GENTA INCORPORATED /DE/
8-K, 1996-10-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: FIDELITY ABERDEEN STREET TRUST, 485BPOS, 1996-10-10
Next: GIBRALTAR PACKAGING GROUP INC, 10-K405, 1996-10-10



<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT




     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



Date of Report (Date of earliest event reported): October 8, 1996



                               GENTA INCORPORATED
             (Exact name of registrant as specified in its charter)

                         Commission file number 0-19635

          DELAWARE                                    33-0326866
     (State or other jurisdiction of    (IRS Employer Identification Number)
     incorporation or organization)


                 3550 GENERAL ATOMICS COURT, SAN DIEGO, CA 92121
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (619) 455-2700
              (Registrant's telephone number, including area code)

<PAGE>

                               GENTA INCORPORATED

                                    FORM 8-K

                                 CURRENT REPORT

                                TABLE OF CONTENTS



Item 6.   Resignations of Registrant's Directors

Item 7.   Financial Statements and Exhibits

Signature


                                       -2-
<PAGE>

ITEM 6.   RESIGNATIONS OF REGISTRANT'S DIRECTORS

     By letter dated October 8, 1996, James C. Blair, Ph.D. announced that he 
would be resigning as a Director and as Vice Chairman of the Board of 
Directors of Genta Incorporated (the "Company"), effective immediately.
Dr. Blair cited as the reason for the resignation his perception that his views
regarding the proper program to resolve the financial and strategic issues 
faced by the Company were irreconcilably different from those held by the 
Company's Chairman of the Board and by a majority of the Company's Board of 
Directors.

ITEM 7.   FINANCIAL STATEMENTS AND EXHIBITS

     (c)  Exhibits

          17.1      Resignation letter of James C. Blair, Ph.D., dated
                    October 8, 1996.


                                       -3-

<PAGE>

                                    SIGNATURE


     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                     GENTA INCORPORATED



Date:  October 10, 1996                         /s/ Thomas H. Adams
                                     -----------------------------------------
                                                   Thomas H. Adams
                                     Chairman of the Board and Chief Executive
                                                       Officer


                                       -4-

<PAGE>

                                  EXHIBIT INDEX

Exhibit
Number                             Description
- -------                            -----------

17.1      Resignation letter of James C. Blair, Ph.D., dated October 8, 1996.


                                       -5-

<PAGE>

                                DOMAIN ASSOCIATES
                             PRINCETON - COSTA MESA


GENERAL PARTNERS
James C. Blair
Brian H. Dovey
Richard S. Schneider
Kathleen K. Schoemaker
Jesse I. Treu

RESEARCH PARTNER
Arthur J. Klausner


October 8, 1996

VIA FACSIMILE - ORIGINAL TO FOLLOW VIA MAIL

Thomas H. Adams, Ph.D.
Genta Incorporated
3550 General Atomics Court
Building 9, 2nd Floor
San Diego, CA 92121-1194

Dear Tom:

Confirming what I said during our telephone call after last night's telephonic
Board Meeting, I hereby resign as Vice Chairman and a Director of Genta
effective immediately.

I am resigning due to my perception that I have irreconcilably different views
than those held by you and the majority of the Board as to the proper program to
resolve the financial and strategic issues which Genta faces.

I hope you and the remaining members of the Genta Board are successful in
preserving shareholder value.  We all have a lot at stake.

Yours truly,

/s/ James C. Blair

James C. Blair

cc:  Samuel D. Colella
     David F. Hale
     Robert E. Klem
     Paul O.P Ts'o, Ph.D.
     Sharon Webster, Ph.D.
     Howard Sampson
     Thomas E. Sparks, Esq.
     John MacMurray, Esq.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission